Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (Diabody)
TypeName: Business Offer
Category:
Offer Date:2019/03/22
Country: United States
Summary: Recombinant Anti-CD3 x Anti-PD1 Bispecific Antibody (Diabody) is designed to be expressed as two polypeptide chains respectively. The two chains are cross-over pairing to form a dimer. It contains a His-tag for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Esophageal cancer; Hodgkin lymphoma; Renal cell cancer (RCC); Mesothelioma; Head and neck squamous cell cancer (HNSCC); Anal cancer; Gastric cancer; Hepatocellular cancer; Nasopharyngeal cancer; Non-small cell lung cancer (NSCLC); Solid tumors therapy. https://www.creative-biolabs.com/bsab/symbolsearch-cd3%2520%2526%2520pd1.htm
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
